336 related articles for article (PubMed ID: 6826727)
1. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
Sassa S; Kappas A
J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
[TBL] [Abstract][Full Text] [Related]
2. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
Sassa S; Kappas A
Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
[TBL] [Abstract][Full Text] [Related]
3. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
Sassa S; Fujita H; Kappas A
Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
[TBL] [Abstract][Full Text] [Related]
4. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.
Grenier A; Lescault A; Laberge C; Gagné R; Mamer O
Clin Chim Acta; 1982 Aug; 123(1-2):93-9. PubMed ID: 7116642
[TBL] [Abstract][Full Text] [Related]
5. Effect of succinylacetone on heme and cytochrome P450 synthesis in hepatocyte culture.
Giger U; Meyer UA
FEBS Lett; 1983 Mar; 153(2):335-8. PubMed ID: 6617864
[TBL] [Abstract][Full Text] [Related]
6. The effects of succinylacetone (4,6-dioxoheptanoic acid) on delta-aminolevulinate synthase activity and the content of heme in monolayers of chick embryo liver cells.
Schoenfeld N; Greenblat Y; Epstein O; Atsmon A
Biochim Biophys Acta; 1982 Dec; 721(4):408-17. PubMed ID: 7159602
[TBL] [Abstract][Full Text] [Related]
7. Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells.
Ebert PS; Hess RA; Frykholm BC; Tschudy DP
Biochem Biophys Res Commun; 1979 Jun; 88(4):1382-90. PubMed ID: 289386
[No Abstract] [Full Text] [Related]
8. On the enzymic defects in hereditary tyrosinemia.
Lindblad B; Lindstedt S; Steen G
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
[TBL] [Abstract][Full Text] [Related]
9. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
Berger R; van Faassen H; Smith GP
Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
[TBL] [Abstract][Full Text] [Related]
10. On rat renal aminolevulinate transport and metabolism in experimental Fanconi syndrome.
Roth KS; Carter BE; Moses LC; Spencer PD
Biochem Med Metab Biol; 1990 Dec; 44(3):238-46. PubMed ID: 2288767
[TBL] [Abstract][Full Text] [Related]
11. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
Manabe S; Sassa S; Kappas A
J Exp Med; 1985 Sep; 162(3):1060-74. PubMed ID: 3928801
[TBL] [Abstract][Full Text] [Related]
12. Renal heme metabolism in hereditary tyrosinemia: use of succinylacetone in rat renal tubules.
Wyss PA; Carter BE; Boynton SB; Connor E; Fowler B; Roth KS
Biochim Biophys Acta; 1991 Dec; 1070(2):300-4. PubMed ID: 1764448
[TBL] [Abstract][Full Text] [Related]
13. Induction of delta-aminolevulinic acid dehydratase in mouse Friend virus-transformed erythroleukemia cells during erythroid differentiation.
Chang CS; Sassa S
Blood; 1984 Jul; 64(1):64-70. PubMed ID: 6587918
[TBL] [Abstract][Full Text] [Related]
14. Iron utilization in rabbit reticulocytes. A study using succinylacetone as an inhibitor or heme synthesis.
Ponka P; Wilczynska A; Schulman HM
Biochim Biophys Acta; 1982 Feb; 720(1):96-105. PubMed ID: 7059619
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
[TBL] [Abstract][Full Text] [Related]
16. Iron mobilization by succinylacetone methyl ester in rats. A model study for hereditary tyrosinemia and porphyrias characterized by 5-aminolevulinic acid overload.
Rocha ME; Bandy B; Costa CA; de Barros MP; Pinto AM; Bechara EJ
Free Radic Res; 2000 Apr; 32(4):343-53. PubMed ID: 10741855
[TBL] [Abstract][Full Text] [Related]
17. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
Tuchman M; Freese DK; Sharp HL; Ramnaraine ML; Ascher N; Bloomer JR
J Pediatr; 1987 Mar; 110(3):399-403. PubMed ID: 3546650
[TBL] [Abstract][Full Text] [Related]
18. Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.
Stoner E; Starkman H; Wellner D; Wellner VP; Sassa S; Rifkind AB; Grenier A; Steinherz PG; Meister A; New MI
Pediatr Res; 1984 Dec; 18(12):1332-6. PubMed ID: 6522148
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
Kvittingen EA; Leonard JV; Pettit BR; King GS
Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
[TBL] [Abstract][Full Text] [Related]
20. Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.
Puy H; Deybach JC; Bogdan A; Callebert J; Baumgartner M; Voisin P; Nordmann Y; Touitou Y
J Clin Invest; 1996 Jan; 97(1):104-10. PubMed ID: 8550820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
